Original Article

You have full text access to this OnlineOpen article

Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy

  1. Fadi Braiteh MD1,
  2. Arlene M. Correa PhD2,
  3. Wayne L. Hofstetter MD2,
  4. David C. Rice MD2,
  5. Ara A. Vaporciyan MD2,
  6. Garrett L. Walsh MD2,
  7. Jack A. Roth MD2,
  8. Reza J. Mehran MD2,
  9. Stephen G. Swisher MD2,
  10. Jaffer A. Ajani MD1,†,*

Article first published online: 26 JUN 2009

DOI: 10.1002/cncr.24488

Issue

Cancer

Cancer

Volume 115, Issue 19, pages 4450–4458, 1 October 2009

Additional Information

How to Cite

Braiteh, F., Correa, A. M., Hofstetter, W. L., Rice, D. C., Vaporciyan, A. A., Walsh, G. L., Roth, J. A., Mehran, R. J., Swisher, S. G. and Ajani, J. A. (2009), Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer, 115: 4450–4458. doi: 10.1002/cncr.24488

Author Information

  1. 1

    Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  2. 2

    Department of Thoracic and Cardiovascular Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas

  1. †

    Fax: (713) 745-1163

*Department of Gastrointestinal Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Unit 0426, 1515 Holcombe Boulevard, Houston, TX 77030-4009

Publication History

  1. Issue published online: 17 SEP 2009
  2. Article first published online: 26 JUN 2009
  3. Manuscript Received: 21 OCT 2009
  4. Manuscript Accepted: 9 FEB 2009
  5. Manuscript Revised: 4 FEB 2009

Funded by

  • The University of Texas M. D. Anderson Cancer Center
  • Park, Dallas, Cantu, and Smith Families
  • River Creek Foundation

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (211K)

References

  • 1
    Brown LM, Devesa SS, Chow WH. Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst. 2008; 100: 1184-1187.
  • 2
    Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008. CA Cancer J Clin. 2008; 58: 71-96.
    Direct Link:
  • 3
    Ajani JA, Winter K, Komaki R, et al. Phase II randomized trial of 2 nonoperative regimens of induction chemotherapy followed by chemoradiation in patients with localized carcinoma of the esophagus: RTOG 0113. J Clin Oncol. 2008; 26: 4551-4556.
  • 4
    Kelsen DP, Winter KA, Gunderson LL, et al. Long-term results of RTOG trial 8911 (USA Intergroup 113): a random assignment trial comparison of chemotherapy followed by surgery compared with surgery alone for esophageal cancer. J Clin Oncol. 2007; 25: 3719-3725.
  • 5
    Internullo E, Moons J, Nafteux P, et al. Outcome after esophagectomy for cancer of the esophagus and GEJ in patients aged over 75 years. Eur J Cardiothorac Surg. 2008; 33: 1096-1104.
  • 6
    Morita M, Egashira A, Yoshida R, et al. Esophagectomy in patients 80 years of age and older with carcinoma of the thoracic esophagus. J Gastroenterol. 2008; 43: 345-351.
  • 7
    Rice DC, Correa AM, Vaporciyan AA, et al. Preoperative chemoradiotherapy prior to esophagectomy in elderly patients is not associated with increased morbidity. Ann Thorac Surg. 2005; 79: 391-397; discussion 391-397.
  • 8
    Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B. The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer. 2008; 8: 288-298.
  • 9
    Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998; 85: 1457-1459.
    Direct Link:
  • 10
    GreeneFL, ComptonCC, FritzAG, ShahJ, WinchesterDP, eds. AJCC Cancer Staging Atlas. New York, NY: Springer; 2006.
  • 11
    Ajani J, Bekaii-Saab T, D'Amico TA, et al. Esophageal cancer clinical practice guidelines. J Natl Compr Canc Netw. 2006; 4: 328-347.
  • 12
    Chirieac LR, Swisher SG, Ajani JA, et al. Post-therapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer. 2005; 103: 1347-1355.
    Direct Link:
  • 13
    Bilimoria KY, Bentrem DJ, Feinglass JM, et al. Directing surgical quality improvement initiatives: comparison of perioperative mortality and long-term survival for cancer surgery. J Clin Oncol. 2008; 26: 4626-4633.
  • 14
    Birkmeyer JD, Stukel TA, Siewers AE, Goodney PP, Wennberg DE, Lucas FL. Surgeon volume and operative mortality in the United States. N Engl J Med. 2003; 349: 2117-2127.
  • 15
    Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346: 1128-1137.
  • 16
    Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg. 2000; 119: 1126-1132.
  • 17
    Lagarde SM, Reitsma JB, Maris AK, et al. Preoperative prediction of the occurrence and severity of complications after esophagectomy for cancer with use of a nomogram. Ann Thorac Surg. 2008; 85: 1938-1945.
  • 18
    Lagarde SM, de Boer JD, ten Kate FJ, Busch OR, Obertop H, van Lanschot JJ. Postoperative complications after esophagectomy for adenocarcinoma of the esophagus are related to timing of death due to recurrence. Ann Surg. 2008; 247: 71-76.
  • 19
    Lagarde SM, Reitsma JB, de Castro SM, Ten Kate FJ, Busch OR, van Lanschot JJ. Prognostic nomogram for patients undergoing oesophagectomy for adenocarcinoma of the oesophagus or gastro-oesophageal junction. Br J Surg. 2007; 94: 1361-1368.
    Direct Link:
  • 20
    Lagarde SM, ten Kate FJ, Reitsma JB, Busch OR, van Lanschot JJ. Prognostic factors in adenocarcinoma of the esophagus or gastroesophageal junction. J Clin Oncol. 2006; 24: 4347-4355.
View Full Article (HTML) Get PDF (211K)